Search

Your search keyword '"Milicic, D."' showing total 394 results

Search Constraints

Start Over You searched for: Author "Milicic, D." Remove constraint Author: "Milicic, D."
394 results on '"Milicic, D."'

Search Results

4. Lower Platelet Count Following Induction with Antithymocyte Globulin is Associated with a Lower Incidence of Cardiac Allograft Vasculopathy

5. Intravenous angiotensin II as an add-on to standard of care vasopressors in patients with refractory shock on mechanical circulatory support: a single centre retrospective case series

6. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

7. Predominance of a rare transthyretin mutation (p.Asp38Glu) in patients with hATTR cardiomyopathy: initial data from the Croatian Transthyretin Cardiac Amyloidosis Registry (CroATTR)

8. Incidence of restenosis after drug-coated balloon percutaneous coronary intervention in patients with diabetes mellitus - a single-centre experience

12. Heart failure in patients is associated with downregulation of mitochondrial quality control genes.

14. The case against premature treatment of heart failure patients with implantable cardioverter-defibrillators: results from an institutional registry

15. Relation between sex and mortality after myocardial infarction in high-income and middle-income European countries

16. Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure

17. Prevalence of standard modifiable cardiovascular risk factors in patients with ST segment elevation myocardial infarction and its relation with outcomes

19. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

20. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

21. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

22. Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

23. Is early percutaneous coronary intervention safe in patients ACS and cancer?

26. Cardiac emergencies following earthquake

28. Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

29. Impact analysis of heart failure across European countries: an ESC-HFA position paper

30. Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome

31. Hybrid Dorsal Preservation Rhinoplasty: How We Do It

32. Acute heart failure: a mechanism underscoring sex differences in outcomes following acute coronary syndromes

33. IS A FAMILY HISTORY OF CORONARY HEART DISEASE AN INDEPENDENT CARDIOVASCULAR RISK FACTOR?

35. Statins for primary prevention among elderly men and women

37. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

38. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

39. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

40. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology

41. Comprehensive assessment of myocardial remodeling in ischemic heart disease by synchrotron propagation based X-ray phase contrast imaging

42. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)

45. His pacing program: a 2-year single-centre experience

46. Mortality, appropriate and inappropriate shocks - observations from an institutional implantable cardioverter defibrillator registry

47. Cardioverter-related complications: observations from an institutional implantable cardioverter defibrillator registry

48. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Catalog

Books, media, physical & digital resources